.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
.
.yesterday they welcomed the findings of coroner patrick mcgurgan, who criticised the staff caring for mrs cavanagh over a series of missed opportunities..